300015.SZ深圳证券交易所 · 创业板 ChiNext
Aier Eye Hospital Group 爱尔眼科
Healthcare Services 医疗服务
¥7.86−¥0.05 · −0.63%
Open 开盘
¥7.91
High 最高
¥7.98
Low 最低
¥7.84
Prev Close 昨收
¥7.91
Volume 成交量
3,640.4万股
Turnover 成交额
¥2.87亿
Mkt Cap 总市值
¥731亿
P/E 市盈率
28.7×
Recent Activity 近期动态All Filings 全部公告 →
7 significant filings since 31 May 2026: 1 on share pledge, 3 on buyback and 1 on pledge released, and 2 other kinds. The latest, on 15 Sep 2026: 关于注销部分回购股份减少注册资本暨通知债权人的公告. 1 unverified report logged, the latest on 12 Aug 2026.
自 31 May 2026 起有 7 份重大公告：share pledge 1 份、buyback 3 份、pledge released 1 份，另有 2 类。最新一份（15 Sep 2026）：关于注销部分回购股份减少注册资本暨通知债权人的公告。记录了 1 条未经核实的报道，最新一条见于 12 Aug 2026。
8.008.258.508.759.00
Volume 成交量
1.93亿
25 Jun17 Jul10 Aug02 Sep24 Sep
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Relative Value 同业比较
Healthcare Services 医疗服务 · 54 listed peers
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥731亿 | ¥73亿 | 3rd highest of 54 · 54 家中第 3 高 | |
| Trailing P/E 市盈率 | 28.7x | 103.6x | 5th lowest of 38 · 38 家中第 5 低 | |
| P/B 市净率 | 3.2x | 3.4x | 25th lowest of 54 · 54 家中第 25 低 | |
| Revenue Growth 营收增速 | 3.8% | 4.0% | 27th lowest of 54 · 54 家中第 27 低 | |
| Profit Growth 净利增速 | -33.8% | 3.3% | 18th lowest of 54 · 54 家中第 18 低 | |
| Gross Margin 毛利率 | 46.1% | 33.3% | 13th highest of 54 · 54 家中第 13 高 | |
| Net Margin 净利率 | 12.9% | 5.8% | 11th highest of 54 · 54 家中第 11 高 | |
| Return on Equity 净资产收益率 | 6.0% | 2.0% | 7th highest of 54 · 54 家中第 7 高 | |
| Debt to Assets 资产负债率 | 32.6% | 28.7% | 23rd highest of 54 · 54 家中第 23 高 | |
| Grade Score 评级得分 | 60 | 52 | 20th highest of 53 · 53 家中第 20 高 |
Statement figures are for the period to 30 Jun 2026, filed by 54 of 54 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，54 家同业中 54 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
Largest Peers 主要同业
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Wuxi Apptec 药明康德 | ¥4,910亿 | 22.7x | 5.8x | 38.9% | 38.5% | 13.2% | B |
| Pharmaron Beijing 康龙化成 | ¥792亿 | 46.3x | 4.8x | 17.9% | 9.4% | 4.6% | C |
| Aier Eye Hospital Group 爱尔眼科 | ¥731亿 | 28.7x | 3.2x | 3.8% | 12.9% | 6.0% | C |
| Asymchem Laboratories 凯莱英 | ¥653亿 | 63.1x | 3.7x | 13.1% | 14.3% | 2.9% | C |
| Biocytogen 百奥赛图 | ¥568亿 | 155.2x | 23.5x | 51.6% | 25.6% | 10.5% | B |
| Hangzhou Tigermed Consulting 泰格医药 | ¥489亿 | 535.1x | 2.5x | 14.1% | -5.0% | -2.0% | D |
| Joinn 昭衍新药 | ¥340亿 | 34.6x | 3.8x | 5.3% | 106.2% | 8.6% | B |
| Haoyuan Chemexpress 皓元医药 | ¥214亿 | 82.7x | 6.7x | 25.7% | 9.8% | 5.3% | C |
| BGI Genomics 华大基因 | ¥187亿 | — | 2.2x | 9.6% | 2.7% | 0.6% | D |
| Hitgen 成都先导 | ¥175亿 | 124.9x | 11.5x | 52.4% | 23.0% | 5.2% | B |
| Meinian Onehealth Healthcare Holdings 美年健康 | ¥173亿 | 53.2x | 2.2x | -6.4% | -5.0% | -2.2% | E |
| Topchoice Medical 通策医疗 | ¥148亿 | 24.0x | 3.6x | 4.1% | 32.8% | 9.5% | C |
| Jiuzhou Pharma 九洲药业 | ¥145亿 | 24.5x | 1.6x | -10.3% | 14.8% | 4.3% | C |
| Gempharmatech 药康生物 | ¥144亿 | 78.8x | 6.3x | 22.6% | 24.1% | 4.8% | B |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。